Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease
- 1 July 2001
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 157 (1) , 57-64
- https://doi.org/10.1016/s0021-9150(00)00705-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasminogen Activator Inhibitor-1 Promoter 4G/5G Genotype and Plasma Levels in Relation to a History of Myocardial Infarction in Patients Characterized by Coronary AngiographyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Relations Between Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Insulin Resistance, Glucose Intolerance, Hyperinsulinemia, and DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- The ACE of heartsNature, 1992
- Twin Studies in Metabolic DiseasesAnnals of Medicine, 1992
- Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Angiotensin-converting enzyme: new concepts concerning its biological roleBiochemistry, 1989
- Genetic--epidemiologic study of early-onset ischemic heart disease.Circulation, 1980
- The investigation of linkage between a quantitative trait and a marker locusBehavior Genetics, 1972